You can buy or sell Morphic and other stocks, options, ETFs, and crypto commission-free!
Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. Read More The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA. The listed name for MORF is Morphic Holding, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 12, Pre-Market